Divis Laboratories Ltd

Divi's Lab. | 532488

Market Closed

₹9,165.00

₹302.00 (-3.19%)

As on 02/09/26, 1:23 AM

Market Cap2,43,301.95 CR

Current Price₹9,165

High / Low₹9,467 / 5,636.5

PE Ratio61.36

Book Value₹632.49

Dividend Yield0.50%

ROCE21.00%

ROE16.50%

Face Value₹2.00

Current Vol.4,85,620

Average Vol.---

ISININE361B01024

PB Ratio9.4

Debt to Equity0

Net Profit Margin24.32

Operating Margin36.7

DIVISLAB - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹9,467₹9,251.5

₹9,165

Previous CloseToday's Open

₹5,636.5₹9,467

₹9,165

52W Low52W High

₹9,251.5Today's Open

₹9,467Previous Close

4,85,620Volume

₹5,636.552W Low

₹9,46752W High

Ratios

No data available

About Company

Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals
The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries
It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports
Presently, it works 6 manufacturing units and market presence across several countries
The company has two subsidiaries M/s
Divis Laboratories (USA) Inc
, in the United States of America and M/s
Divi's Laboratories Europe AG in Switzerland for marketing its Nutra products and to provide a greater reach to customers within these regions
The company has Research Centers at Sanathnagar, Hyderabad and at the manufacturing sites
Research Centre at Sanathnagar primarily focuses on custom synthesis, contract research for MNC companies as also future generics involving processes like route design, route selection, establishing gram scale process and structural confirmation

Ethics: Divis Laboratories Ltd is flagged for

Maybe indirectly supporting non-vegan business

The company does not practice animal cruelty itself, but may be linked to businesses that do.

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI83.63

SMA 208633.67

SMA 507729.61

SMA 1007149.02

SMA 2006716.60

SMA 108834.65

MACD_12_26_Days401.00

EMA10Day8921.46

EMA20Day8611.60

EMA50Day7964.39

MACD_12_26_9_Days40.72

EMA100Day7415.66

EMA200Day6950.13

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth12.82%

ROE16.19%

EBITDA Margin36.70%

All figures in ₹ Crores

Indicators	2026	2025	2024	2023	2022
Revenue	10,560.00	9,360.00	7,845.00	7,767.51	8,959.83
Interest	23.00	2.00	3.00	0.67	0.80
Expenses	7,119.00	6,392.00	5,640.00	5,399.69	5,077.89
Financing Profit	3,948.00	3,320.00	2,544.00	2,712.48	3,995.81
Financing Margin %	37%	35%	32%	35%	45%
Other Income	507.00	352.00	339.00	344.66	113.87
Depreciation	463.00	402.00	378.00	343.18	311.51
Profit before tax	3,388.00	2,916.00	2,163.00	2,368.63	3,683.50
Tax %	24%	25%	26%	23%	20%
Net Profit	2,568.00	2,191.00	1,600.00	1,823.38	2,960.45
EPS in Rs	96.75	82.53	60.27	68.69	111.52

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
GOLDMAN SACHS BANK EUROPE SE - ODI	09 Oct ‘25	Purchase	33,108	₹6,120.5	9.84%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	09 Oct ‘25	Sell	33,108	₹6,120.5	9.84%
THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849	14 Jul ‘25	Purchase	21,874	₹6,835	2.26%
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828	14 Jul ‘25	Sell	21,874	₹6,835	2.26%
PI OPPORTUNITIES AIF V LLP	06 Nov ‘24	Purchase	80,324	₹5,979.65	12.97%
PRAZIM TRADING AND INVESTMENT COMPANY PRIVATE LIMITED	06 Nov ‘24	Sell	80,324	₹5,979.65	12.97%
ISHARES CORE MSCI EMERGING MARKETS ETF	14 Nov ‘22	Purchase	2,09,124	₹3,271.4	19.33%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	14 Nov ‘22	Sell	2,09,124	₹3,271.4	19.33%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Nov ‘22	Purchase	2,09,125	₹3,781.45	48.39%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Nov ‘22	Sell	2,09,125	₹3,781.45	48.39%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

10 Aug 2026

AGM

23 May 2026

24 Jul 2026

Final Dividend (₹30)

Recommended a final dividend of Rs.30/- (i.e. 1,500%) per equity share of face value Rs.2/- each for the financial year 2025-26, subject to approval of the members at the ensuing 36th Annual General Meeting (AGM). The dividend shall be paid within specified timelines from the conclusion of the AGM

23 May 2026

11 Aug 2025

AGM

17 May 2025

25 Jul 2025

Final Dividend (₹30)

As per enclosed letter. Recommended a final dividend of 30/- (i.e. 1,500%) per equity share of face value 2/-each for the financial year 2024-25, subject to approval of the members at the ensuing 35th Annual General Meeting (AGM). The dividend shall be paid within specified timelines from the conclusion of the AGM. The 35th AGM of the Members of the Company will be held on Monday, August 11, 2025. The record date for the purpose of the payment of dividend is July 25, 2025.

17 May 2025

12 Aug 2024

AGM

25 May 2024

02 Aug 2024

Final Dividend (₹30)

As per enclosed letter. Recommended a final dividend of ? 30/- (i.e. 1,500%) per equity share of face value ? 2/- each for the financial year 2023-24, subject to approval of the members at the ensuing 34th Annual General Meeting (AGM). The dividend shall be paid within specified timelines from the conclusion of the AGM

25 May 2024

28 Aug 2023

AGM

03 Jul 2023

11 Aug 2023

Final Dividend (₹30)

Recommended a Dividend of ? 30/- (i.e. 1,500%) per equity share of face value ? 2/- each for the financial year 2022-23, subject to approval of the members at the ensuing 33rd Annual General Meeting (AGM). The dividend shall be credited / warrants thereof dispatched within specified timelines from the conclusion of the AGM. The AGM date and record date for the purpose of the payment of dividend will be announced in due course.

20 May 2023

22 Aug 2022

AGM

04 Jul 2022

12 Aug 2022

Final Dividend (₹30)

Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2022, inter alia, has recommended a Dividend of Rs. 30/- (i.e. 1500%) per equity share of face value Rs. 2/- each for the financial year 2021-22, subject to approval of the members at the ensuing 32nd Annual General Meeting (AGM). The dividend shall be credited/ warrants thereof dispatched within 30 (thirty) days from the conclusion of the AGM.

23 May 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
9,165	2,43,302	82	15	70	0	24.32%
1,930	4,63,180	37	6	30	0	19.78%
4,959	1,88,623	85	22	50	1	11.09%
1,164	1,16,114	24	4	18	0	9.82%
1,418	1,14,554	32	3	24	0	9.92%
1,860	1,00,498	92	19	64	1	13.06%
2,150	98,312	17	4	13	0	19.16%
1,171	97,741	30	3	18	0	12.34%
2,360	97,467	46	6	32	0	13.57%
1,683	96,836	26	3	17	0	10.41%

Showing 10 of 140 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in just 5 minutes*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

EPLEPL Ltd
₹240.35-21.71 (-8.28%)

Group Stocks

Adani Stocks

Tata Group Stocks

Frequently Asked Questions

What is Share Price of Divis Laboratories Ltd?

The current share price of Divis Laboratories Ltd (Divi's Lab.) is ₹9165.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Divis Laboratories Ltd?

The Price-to-Earnings (P/E) ratio of Divis Laboratories Ltd is 9165.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Divis Laboratories Ltd?

Divis Laboratories Ltd has a 52-week high of ₹9467.00 and a 52-week low of ₹5636.50. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Divis Laboratories Ltd?

Divis Laboratories Ltd offers a dividend yield of 0.32%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Divis Laboratories Ltd?

The Earnings Per Share (EPS) of Divis Laboratories Ltd is ₹112.23. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Divis Laboratories Ltd?

Divis Laboratories Ltd has a Return on Equity (ROE) of 16.50%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video